1646MO Phase II ATLEP trial: Final results for lenvatinib/pembrolizumab in metastasized anaplastic and poorly differentiated thyroid carcinoma
Authors:
- C. DierksCDC. Dierks
- J. RufJRJ. Ruf
- J. SeufertJSJ. Seufert
- M. KreisslMKM. Kreissl
- C. KleinCKC. Klein
- C. SpitzwegCSC. Spitzweg
- M. KroissMKM. Kroiss
- O. ThomuschOTO. Thomusch
- K. LorenzKLK. Lorenz
- A. ZielkeAZA. Zielke
- C. MiethingCMC. Miething
- 13 September 2022
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 33 (7) , S1295